Liyan Xue

12PUBLICATIONS
37CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Tumour immunologyCancer geneticsCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|May 09, 2025
Predictive factors for neoadjuvant combined immunotherapy in gastric adenocarcinoma: Focusing on the primitive enterocyte phenotype and PVR.

Bingzhi Wang, Yinong Wang, Yongjian Zhu

|Nov 15, 2024
Chemoradiotherapy and Subsequent Immunochemotherapy as Conversion Therapy in Unresectable Locally Advanced Esophageal Squamous Cell Carcinoma: A Phase II NEXUS-1 Trial.

Xin Wang, Xiaozheng Kang, Ruixiang Zhang

|Oct 22, 2024
Single-cell sequencing reveals immune features of treatment response to neoadjuvant immunochemotherapy in esophageal squamous cell carcinoma.

Zhenlin Yang, He Tian, Xiaowei Chen

|Nov 29, 2023
Gastric tubular adenocarcinoma with diffuse neutrophils infiltrating: characteristics and probable treatment strategy.

Bingzhi Wang, Yongjian Zhu, Shaoming Wang

|Nov 17, 2022
The prognostic significance of the circumferential resection margin in esophageal squamous cell carcinoma patients without neoadjuvant treatment.

Zhaoyang Yang, Hua Lin, Zhen Wang

|Nov 13, 2022
Integrated molecular characterization of esophageal basaloid squamous cell carcinoma: a subtype with distinct RNA expression pattern and immune characteristics, but no specific genetic mutations.

Yan Li, Linxiu Liu, Yi Pan

Pageof 2

Frequent Collaborators

3 joint publications

Yang Li

2 joint publications

Fuhai Ma

2 joint publications

Weikun Li

2 joint publications

Wenzhe Kang